Search results
Pleasing Signs As A Number Of Insiders Buy Aprea Therapeutics Stock
Simply Wall St. via Yahoo Finance· 38 minutes agoUsually, when one insider buys stock, it might not be a monumental event. But when multiple insiders...
Viridian Therapeutics (NASDAQ:VRDN) Earns Outperform Rating from Analysts at Wolfe Research
ETF DAILY NEWS· 5 hours agoInvestment analysts at Wolfe Research started coverage on shares of Viridian Therapeutics (NASDAQ:VRDN – Get Free Report) in a note issued to investors on Tuesday, Briefing.com ...
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time...
Motley Fool via Yahoo Finance· 3 hours agoShares of Structure Therapeutics (NASDAQ: GPCR) shot up more than 50% during the first week of June....
CytoMed Therapeutics’ (GDTC) Speculative Buy Rating Reiterated at Benchmark
ETF DAILY NEWS· 4 hours agoCytoMed Therapeutics (NASDAQ:GDTC – Get Free Report)‘s stock had its “speculative buy” rating restated by analysts at Benchmark in a note issued to investors on Tuesday, Benzinga ...
Here’s Why Viking Therapeutics (VKTX) Shares Rose in Q1
Insider Monkey via Yahoo Finance· 1 hour agoBaron Funds, an investment management company, released its “Baron Opportunity Fund” first quarter...
Brokerages Set Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Target Price at $64.86
ETF DAILY NEWS· 10 hours agoArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven research firms that are covering the ...
Enliven Therapeutics, Inc. (NASDAQ:ELVN) COO Anish Patel Sells 1,133 Shares
ETF DAILY NEWS· 7 hours agoEnliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) COO Anish Patel sold 1,133 shares of the firm’s stock in a transaction dated Thursday, June 6th. The stock was sold ...
Fate Therapeutics, Inc. (NASDAQ:FATE) Given Average Recommendation of “Hold” by Analysts
ETF DAILY NEWS· 10 hours agoFate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) has earned a consensus recommendation of “Hold” from the fourteen analysts that are presently covering the firm, MarketBeat ...
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals | The Motley Fool
The Motley Fool· 23 hours agoViking Therapeutics (VKTX 0.70%) and Madrigal Pharmaceuticals (MDGL 4.31%) are highly prominent...
Enliven Therapeutics COO sells over $22k in company stock By Investing.com
Investing.com· 13 hours agoEnliven Therapeutics, Inc. (NASDAQ:ELVN) has reported a recent transaction involving its Chief...